Here, the authors show that in PDA cells redox and central carbon metabolism are driven by an eIF4F dependent translation program, and combined targeting of eIF4A and glutaminase can impact PDA proliferation. The gene discussed is EIF4G1; the disease is Patent ductus arteriosus.